Epigenetic Targets in Synovial Sarcoma: A Mini-Review

por Hale, Ryland, Sandakly, Sami, Shipley, Janet, Walters, Zoë
Publicado 2019

Acute exacerbations of chronic rhinosinusitis: The current state of knowledge

por Walters, Zoe A., Sedaghat, Ahmad R., Phillips, Katie M.
Publicado 2022

Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma

por Pickering, Oliver J., Breininger, Stella P., Underwood, Timothy J., Walters, Zoë S.
Publicado 2021

The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review

por Murage, Nora Wangari, Ahmed, Nada Mabrouk, Underwood, Timothy J., Walters, Zoë S., Breininger, Stella Panagio
Publicado 2023

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

por O’Brien, Eleanor M., Selfe, Joanna L., Martins, Ana Sofia, Walters, Zoë S., Shipley, Janet M.
Publicado 2018

MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas

por Missiaglia, Edoardo, Shepherd, Chris J., Aladowicz, Ewa, Olmos, David, Selfe, Joanna, Pierron, Gaëlle, Delattre, Olivier, Walters, Zoe, Shipley, Janet
Publicado 2017

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A

por Walters, Zoë S., Aladowicz, Ewa, Villarejo-Balcells, Barbara, Nugent, Gary, Selfe, Joanna L., Eve, Paul, Blagg, Julian, Rossanese, Olivia, Shipley, Janet
Publicado 2021

JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells

por Walters, Zoë S, Villarejo-Balcells, Barbara, Olmos, David, Buist, Thomas WS, Missiaglia, Edoardo, Allen, Rebecca, Al-Lazikani, Bissan, Garrett, Michelle D, Blagg, Julian, Shipley, Janet
Publicado 2013

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma

por Pomella, Silvia, Danielli, Sara G., Alaggio, Rita, Breunis, Willemijn B., Hamed, Ebrahem, Selfe, Joanna, Wachtel, Marco, Walters, Zoe S., Schäfer, Beat W., Rota, Rossella, Shipley, Janet M., Hettmer, Simone
Publicado 2023

Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma

por Izadi, Fereshteh, Sharpe, Benjamin P., Breininger, Stella P., Secrier, Maria, Gibson, Jane, Walker, Robert C., Rahman, Saqib, Devonshire, Ginny, Lloyd, Megan A., Walters, Zoë S., Fitzgerald, Rebecca C., Rose-Zerilli, Matthew J. J., Underwood, Tim J.
Publicado 2021

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

por O’Brien, Eleanor, Tse, Carmen, Tracy, Ian, Reddin, Ian, Selfe, Joanna, Gibson, Jane, Tapper, William, Pengelly, Reuben J., Gao, Jinhui, Aladowicz, Ewa, Petts, Gemma, Thway, Khin, Popov, Sergey, Kelsey, Anna, Underwood, Timothy J., Shipley, Janet, Walters, Zoë S.
Publicado 2023

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas

por Milton, Christopher I., Selfe, Joanna, Aladowicz, Ewa, Man, Stella Y. K., Bernauer, Carolina, Missiaglia, Edoardo, Walters, Zoë S., Gatz, Susanne A., Kelsey, Anna, Generali, Melanie, Box, Gary, Valenti, Melanie, de Haven‐Brandon, Alexis, Galiwango, David, Hayes, Angela, Clarke, Matthew, Izquierdo, Elisa, Gonzalez De Castro, David, Raynaud, Florence I., Kirkin, Vladimir, Shipley, Janet M.
Publicado 2021

Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

por Sharpe, Benjamin P., Hayden, Annette, Manousopoulou, Antigoni, Cowie, Andrew, Walker, Robert C., Harrington, Jack, Izadi, Fereshteh, Breininger, Stella P., Gibson, Jane, Pickering, Oliver, Jaynes, Eleanor, Kyle, Ewan, Saunders, John H., Parsons, Simon L., Ritchie, Alison A., Clarke, Philip A., Collier, Pamela, Mongan, Nigel P., Bates, David O., Yacqub-Usman, Kiren, Garbis, Spiros D., Walters, Zoë, Rose-Zerilli, Matthew, Grabowska, Anna M., Underwood, Timothy J.
Publicado 2022

8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors

por Bavetsias, Vassilios, Lanigan, Rachel M., Ruda, Gian Filippo, Atrash, Butrus, McLaughlin, Mark G., Tumber, Anthony, Mok, N. Yi, Le Bihan, Yann-Vaï, Dempster, Sally, Boxall, Katherine J., Jeganathan, Fiona, Hatch, Stephanie B., Savitsky, Pavel, Velupillai, Srikannathasan, Krojer, Tobias, England, Katherine S., Sejberg, Jimmy, Thai, Ching, Donovan, Adam, Pal, Akos, Scozzafava, Giuseppe, Bennett, James M., Kawamura, Akane, Johansson, Catrine, Szykowska, Aleksandra, Gileadi, Carina, Burgess-Brown, Nicola A., von Delft, Frank, Oppermann, Udo, Walters, Zoe, Shipley, Janet, Raynaud, Florence I., Westaway, Susan M., Prinjha, Rab K., Fedorov, Oleg, Burke, Rosemary, Schofield, Christopher J., Westwood, Isaac M., Bountra, Chas, Müller, Susanne, van Montfort, Rob L. M., Brennan, Paul E., Blagg, Julian
Publicado 2016